Home Updates Audio Conference to Discuss the ACT-AD-Sponsored Study
Featured Image
Update

Audio Conference to Discuss the ACT-AD-Sponsored Study

  November 21, 2017 at 6:02 pm

Avalere Health held an audio conference to discuss the ACT-AD-sponsored study on the way the FDA reviews potential Alzheimer’s disease, HIV/AIDS, and cancer therapies.

See Speaker Presentation

File Attachments
  Audio_Conference_Alzheimers_Disease (170K PDF)
Categories:
Uncategorized
  Recent Updates
Featured Image
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
October 31, 2018
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
June 15, 2018
Researchers Reverse Alzheimer’s Disease in Mouse Models
February 10, 2018
Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease
January 19, 2018
  Newsletter Signup